Loading clinical trials...
Loading clinical trials...
Study of PD-1 Monoclonal Antibody in Combination With Chemotherapy in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Conditions
Interventions
PD-1 combined with chemotherapy
chemotherapy
Locations
1
China
Department of Hematology, Shandong Provincial Hospital
Jinan, Shandong, China
Start Date
November 1, 2019
Primary Completion Date
November 1, 2021
Completion Date
November 1, 2021
Last Updated
October 22, 2019
Lead Sponsor
Shandong Provincial Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions